PAVMZ
Income statement / Annual
Last year (2023), PAVmed Inc's total revenue was $2.45 M,
an increase of 550.40% from the previous year.
In 2023, PAVmed Inc's net income was -$64.18 M.
See PAVmed Inc’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$2.45 M
|
$377,000.00
|
$500,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$9.35 M |
$3.61 M |
$585,000.00 |
$23,000.00 |
$14,226.00 |
$9,790.00 |
$7,110.00 |
$3,793.00 |
$0.00 |
$0.00 |
| Gross Profit |
-$6.90 M |
-$3.24 M |
-$85,000.00 |
-$23,000.00 |
-$14,226.00 |
-$9,790.00 |
-$7,110.00 |
-$3,793.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
-2.81 |
-8.59 |
-0.17 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$14.28 M
|
$25.55 M
|
$19.85 M
|
$10.96 M
|
$6.63 M
|
$4.25 M
|
$2.62 M
|
$1.72 M
|
$489,327.00
|
$22,290.00
|
| General & Administrative
Expenses |
$30.95 M
|
$41.04 M
|
$25.57 M
|
$12.39 M
|
$7.66 M
|
$6.31 M
|
$5.42 M
|
$3.93 M
|
$1.29 M
|
$0.00
|
| Selling & Marketing
Expenses |
$17.58 M
|
$19.32 M
|
$8.90 M
|
$2.79 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$47.62 M
|
$60.36 M
|
$34.46 M
|
$12.39 M
|
$7.66 M
|
$6.31 M
|
$5.42 M
|
$3.93 M
|
$1.29 M
|
$400,000.00
|
| Other Expenses |
-$1.19 M |
$1.78 M |
$0.00 |
$0.00 |
-$558,599.00 |
-$903,000.00 |
-$3.12 M |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$61.90 M |
$87.69 M |
$54.31 M |
$23.35 M |
$14.30 M |
$10.56 M |
$8.03 M |
$5.65 M |
$1.78 M |
$548,768.00 |
| Cost And Expenses |
$71.25 M |
$91.30 M |
$54.89 M |
$23.35 M |
$14.30 M |
$10.56 M |
$8.03 M |
$5.65 M |
$1.78 M |
$548,768.00 |
| Interest Income |
$505,000.00 |
$1.27 M |
$0.00 |
$53,000.00 |
$33,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$589,000.00 |
$1.27 M |
$0.00 |
$53,000.00 |
$32,667.00 |
$2.39 M |
$724,684.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$2.93 M
|
$2.55 M
|
$226,000.00
|
$23,000.00
|
$14,226.00
|
$9,790.00
|
$7,110.00
|
$3,793.00
|
$1.78 M
|
$422,290.00
|
| EBITDA |
-$65.86 M
|
-$92.80 M
|
-$54.17 M
|
-$23.99 M
|
-$15.39 M
|
-$12.07 M
|
-$11.15 M
|
-$5.65 M
|
-$1.78 M
|
-$126,478.00
|
| EBITDA Ratio |
-26.86 |
-246.16 |
-108.33 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
-28.06
|
-241.19
|
-108.79
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$10.47 M
|
-$12.31 M
|
-$1.73 M
|
-$12.54 M
|
-$2.97 M
|
-$4.60 M
|
-$760,466.00
|
-$1.00
|
$0.00
|
-$126,478.00
|
| Income Before Tax |
-$79.26 M |
-$103.24 M |
-$56.13 M |
-$35.89 M |
-$17.27 M |
-$18.17 M |
-$9.52 M |
-$5.65 M |
-$1.78 M |
-$548,768.00 |
| Income Before Tax Ratio
|
-32.33
|
-273.84
|
-112.25
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$12.99 B |
-$1.94 M |
-$5.78 M |
-$1.56 M |
-$1.34 M |
-$204,072.00 |
$878,865.00 |
-$1.00 |
-$1.78 M |
-$126,478.00 |
| Net Income |
-$64.18 M |
-$101.29 M |
-$50.35 M |
-$34.33 M |
-$15.93 M |
-$17.97 M |
-$9.52 M |
-$5.65 M |
-$1.78 M |
-$548,768.00 |
| Net Income Ratio |
-26.17 |
-268.68 |
-100.69 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-8.87 |
-17.06 |
-9.74 |
-10.86 |
-7.91 |
-0.81 |
-0.71 |
-0.44 |
-0.13 |
-0.96 |
| EPS Diluted |
-8.87 |
-17.06 |
-9.74 |
-10.86 |
-7.91 |
-0.81 |
-0.71 |
-0.44 |
-0.13 |
-0.96 |
| Weighted Average Shares
Out |
$7.23 M
|
$5.94 M
|
$5.17 M
|
$3.16 M
|
$2.01 M
|
$22.28 M
|
$13.50 M
|
$12.97 M
|
$13.45 M
|
$574,552.00
|
| Weighted Average Shares
Out Diluted |
$7.23 M
|
$5.94 M
|
$5.17 M
|
$3.16 M
|
$2.01 M
|
$22.28 M
|
$13.50 M
|
$12.97 M
|
$13.45 M
|
$574,552.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
